Short-term prognostic factors in the patients after acute heart failure

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 1, 2015, Pages 1515-1520

  Wang, Xinliang ^a,b   Liu, Yingfeng ^a   Yuan, Yong ^c   Feng, Li ^c   Ning, Ye ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Emergency Centre of Zhongshan City People s Hospital   (China)

^c Zhongshan City Peoples Hospital   (China)

Author keywords

Acute heart failure; Blood glucose; Ejection fraction; N terminal pro brain natriuretic peptide; Prognosis; Systolic blood pressure

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; GLUCOSE;

ACUTE HEART FAILURE; AGED; ARTICLE; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; ECHOGRAPHY; FEMALE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

EID: 84922985438     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O’Connor CM, Sun JL, Yancy CW and Young JB. Cha-racteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 2007; 50: 768-777.
2. Aronow WS. Epidemiology, Pathophysiology, Prognosis, And Treatment of Systolic And Diastolic Heart Failure. Cardiol Rev 2006; 14: 108-124.
3. Owan TE and Redfield MM. Epidemiology of Diastolic Heart Failure. Prog Cardiovasc Dis 2005; 47: 320-332.
4. Lam CS, Donal E, Kraigher-Krainer E and Vasan RS. Epidemiology And Clinical Course of Heart Failure With Preserved Ejection Fraction. Eur J Heart Fail 2011; 13: 18-28.
5. Januzzi JL Jr, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, Tung R, Cameron R, Nagurney JT, Chae CU, Lloyd-Jones DM, Brown DF, Foran-Melanson S, Sluss PM, Lee-Lewandrowski E and Lewandrowski KB. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005; 95: 948-954.
6. Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, Pinto YM and Richards M. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Stu-dy. Eur Heart J 2006; 27: 330-337.
7. Golcuk Y, Golcuk B, Velibey Y, Oray D, Atilla OD, Colak A, Kurtulmus Y, Yildirim A and Eren M. Predictive cutoff point of admission N-terminal pro-B-type natriuretic peptide testing in the ED for prognosis of patients with acute heart failure. Am J Emerg Med 2013; 31: 1191-1195.
8. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O’Connor CM, She L, Stough WG, Yancy CW, Young JB and Fonarow GC. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006; 296: 2217-2226.
9. Kajimoto K, Sato N, Sakata Y and Takano T. Relationship between systolic blood pressure and preserved or reduced ejection fraction at admission in patients hospitalized for acute heart failure syndromes. Int J Cardiol 2013; 168: 4790-4795.
10. Buiciuc O, Rusinaru D, Levy F, Peltier M, Slama M, Leborgne L and Tribouilloy C. Low systolic blood pressure at admission predicts long-term mortality in heart failure with preserved ejection fraction. J Card Fail 2011; 17: 907-915.
11. Murphy M. Low blood pressure and preserved systolic function in elders with heart failure. J Cardiovasc Nurs 2010; 25: 405-410.
12. Haffner SM, Lehto S, Ronnemaa T, Pyorala K and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234.
13. Nusca A, Patti G, Marino F, Mangiacapra F, D’Ambrosio A and Di Sciascio G. Prognostic role of preprocedural glucose levels on short-and long-term outcome in patients undergoing percutaneous coronary revascularization. Catheter Cardiovasc Interv 2012; 80: 377-384.
14. Svensson AM, McGuire DK, Abrahamsson P and Dellborg M. Association between hyper-and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 2005; 26: 1255-1261.
15. Mebazaa A, Gayat E, Lassus J, Meas T, Mueller C, Maggioni A, Peacock F, Spinar J, Harjola VP, van Kimmenade R, Pathak A, Mueller T, Tavazzi L, Disomma S, Metra M, Pascual-Figal D, Laribi S, Logeart D, Nouira S, Sato N, Parenica J, Deye N, Boukef R, Collet C, Van den Berghe G, Cohen-Solal A and Januzzi JL Jr. Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort. J Am Coll Cardiol 2013; 61: 820-829.